Annual Total Long Term Liabilities
$11.03 M
-$18.27 M-62.35%
31 December 2023
Summary:
Inovio Pharmaceuticals annual total long term liabilities is currently $11.03 million, with the most recent change of -$18.27 million (-62.35%) on 31 December 2023. During the last 3 years, it has fallen by -$25.89 million (-70.12%). INO annual total long term liabilities is now -89.65% below its all-time high of $106.56 million, reached on 31 December 2019.INO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$10.02 M
-$638.00 K-5.99%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly total long term liabilities is currently $10.02 million, with the most recent change of -$638.00 thousand (-5.99%) on 30 September 2024. Over the past year, it has dropped by -$1.21 million (-10.75%). INO quarterly long term liabilities is now -95.42% below its all-time high of $218.84 million, reached on 30 June 2020.INO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.4% | -10.8% |
| 3 y3 years | -70.1% | -67.5% |
| 5 y5 years | +25.6% | -89.5% |
INO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.1% | at low | -67.8% | at low |
| 5 y | 5 years | -89.7% | +25.6% | -95.4% | at low |
| alltime | all time | -89.7% | >+9999.0% | -95.4% | >+9999.0% |
Inovio Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.02 M(-6.0%) |
| June 2024 | - | $10.66 M(-5.4%) |
| Mar 2024 | - | $11.27 M(+2.2%) |
| Dec 2023 | $11.03 M(-62.4%) | $11.03 M(-1.7%) |
| Sept 2023 | - | $11.23 M(-4.3%) |
| June 2023 | - | $11.73 M(-4.0%) |
| Mar 2023 | - | $12.22 M(-58.3%) |
| Dec 2022 | $29.30 M(-4.0%) | $29.30 M(-3.5%) |
| Sept 2022 | - | $30.36 M(-1.0%) |
| June 2022 | - | $30.66 M(-1.3%) |
| Mar 2022 | - | $31.07 M(+1.8%) |
| Dec 2021 | $30.53 M(-17.3%) | $30.53 M(-0.9%) |
| Sept 2021 | - | $30.81 M(-2.3%) |
| June 2021 | - | $31.54 M(-0.6%) |
| Mar 2021 | - | $31.72 M(-14.1%) |
| Dec 2020 | $36.93 M(-65.3%) | $36.93 M(-49.1%) |
| Sept 2020 | - | $72.55 M(-66.8%) |
| June 2020 | - | $218.84 M(+84.3%) |
| Mar 2020 | - | $118.77 M(+11.5%) |
| Dec 2019 | $106.56 M(+1113.5%) | $106.56 M(+11.2%) |
| Sept 2019 | - | $95.87 M(+13.4%) |
| June 2019 | - | $84.52 M(+2.1%) |
| Mar 2019 | - | $82.78 M(+842.8%) |
| Dec 2018 | $8.78 M(-6.0%) | $8.78 M(-2.3%) |
| Sept 2018 | - | $8.99 M(-0.4%) |
| June 2018 | - | $9.03 M(-1.8%) |
| Mar 2018 | - | $9.19 M(-1.6%) |
| Dec 2017 | $9.35 M(+43.6%) | $9.35 M(+14.0%) |
| Sept 2017 | - | $8.20 M(+3.2%) |
| June 2017 | - | $7.94 M(+7.8%) |
| Mar 2017 | - | $7.37 M(+13.2%) |
| Dec 2016 | $6.51 M(+1.0%) | $6.51 M(+5.0%) |
| Sept 2016 | - | $6.20 M(-3.2%) |
| June 2016 | - | $6.40 M(-4.1%) |
| Mar 2016 | - | $6.67 M(+3.6%) |
| Dec 2015 | $6.44 M(+4.5%) | $6.44 M(-66.3%) |
| Sept 2015 | - | $19.11 M(+206.9%) |
| June 2015 | - | $6.23 M(-0.7%) |
| Mar 2015 | - | $6.27 M(+1.8%) |
| Dec 2014 | $6.16 M(-4.0%) | $6.16 M(-28.0%) |
| Sept 2014 | - | $8.56 M(+3.4%) |
| June 2014 | - | $8.28 M(+21.1%) |
| Mar 2014 | - | $6.84 M(+6.5%) |
| Dec 2013 | $6.42 M(+236.9%) | $6.42 M(+19.7%) |
| Sept 2013 | - | $5.36 M(+138.3%) |
| June 2013 | - | $2.25 M(+24.8%) |
| Mar 2013 | - | $1.80 M(-5.4%) |
| Dec 2012 | $1.90 M(-13.5%) | $1.90 M(-0.8%) |
| Sept 2012 | - | $1.92 M(-4.3%) |
| June 2012 | - | $2.01 M(-4.8%) |
| Mar 2012 | - | $2.11 M(-4.3%) |
| Dec 2011 | $2.20 M | $2.20 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $2.26 M(-3.3%) |
| June 2011 | - | $2.34 M(-3.4%) |
| Mar 2011 | - | $2.42 M(-4.5%) |
| Dec 2010 | $2.53 M(+2594.1%) | $2.53 M(-1.2%) |
| Sept 2010 | - | $2.56 M(-3.5%) |
| June 2010 | - | $2.65 M(-2.3%) |
| Mar 2010 | - | $2.71 M(+2790.7%) |
| Dec 2009 | $93.90 K(-98.2%) | $93.90 K(-90.7%) |
| Sept 2009 | - | $1.01 M(-81.3%) |
| June 2009 | - | $5.38 M(+5.7%) |
| Mar 2009 | - | $5.09 M(-1.5%) |
| Dec 2008 | $5.17 M(-4.0%) | $5.17 M(+2.9%) |
| Sept 2008 | - | $5.02 M(-2.5%) |
| June 2008 | - | $5.15 M(-2.1%) |
| Mar 2008 | - | $5.26 M(-2.3%) |
| Dec 2007 | $5.39 M(-3.6%) | $5.39 M(+3.0%) |
| Sept 2007 | - | $5.23 M(-2.5%) |
| June 2007 | - | $5.36 M(-1.9%) |
| Mar 2007 | - | $5.47 M(-2.2%) |
| Dec 2006 | $5.59 M(+307.2%) | $5.59 M(+338.3%) |
| Sept 2006 | - | $1.27 M(-2.5%) |
| June 2006 | - | $1.31 M(-1.7%) |
| Mar 2006 | - | $1.33 M(-3.0%) |
| Dec 2005 | $1.37 M(+5999.1%) | $1.37 M(+339.8%) |
| Sept 2005 | - | $312.00 K(-4.7%) |
| June 2005 | - | $327.40 K(-4.6%) |
| Mar 2005 | - | $343.30 K(+8273.2%) |
| Sept 2004 | - | $4100.00(-59.8%) |
| June 2004 | - | $10.20 K(-37.8%) |
| Mar 2004 | - | $16.40 K(-27.1%) |
| Dec 2003 | $22.50 K(-37.3%) | $22.50 K(-15.4%) |
| Sept 2003 | - | $26.60 K(-10.4%) |
| June 2003 | - | $29.70 K(-9.5%) |
| Mar 2003 | - | $32.80 K(-8.6%) |
| Dec 2002 | $35.90 K(-45.2%) | $35.90 K(-11.8%) |
| Sept 2002 | - | $40.70 K(-12.5%) |
| June 2002 | - | $46.50 K(-25.0%) |
| Mar 2002 | - | $62.00 K(-9.1%) |
| Dec 2001 | $65.50 K(-21.5%) | - |
| Sept 2001 | - | $68.20 K(-13.0%) |
| June 2001 | - | $78.40 K(-6.0%) |
| Mar 2001 | - | $83.40 K(-11.1%) |
| Mar 2001 | $83.40 K(+10.8%) | - |
| Dec 2000 | - | $93.80 K(+49.6%) |
| Sept 2000 | - | $62.70 K(-9.4%) |
| June 2000 | - | $69.20 K(-8.1%) |
| Mar 2000 | $75.30 K(-30.0%) | $75.30 K(-24.7%) |
| Dec 1999 | - | $100.00 K(0.0%) |
| Sept 1999 | - | $100.00 K(-50.0%) |
| June 1999 | - | $200.00 K(+85.9%) |
| Mar 1999 | $107.60 K | $107.60 K(-46.2%) |
| Dec 1998 | - | $200.00 K |
FAQ
- What is Inovio Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Inovio Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Inovio Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of INO is $11.03 M
What is the all time high annual total long term liabilities for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual total long term liabilities is $106.56 M
What is Inovio Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, INO annual total long term liabilities has changed by -$18.27 M (-62.35%)
What is Inovio Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of INO is $10.02 M
What is the all time high quarterly long term liabilities for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly total long term liabilities is $218.84 M
What is Inovio Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, INO quarterly total long term liabilities has changed by -$1.21 M (-10.75%)